57148711: Assessing Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast within Northwestern Medicine and Addressing Opportunities for Improvement

Project: Research project

Project Details

StatusFinished
Effective start/end date12/16/19 → 3/31/22

Funding

  • Pfizer Inc. (Letter AGMT 12/16/2019 (Pfizer #57148711))